Complete Filing Data
Aligos Therapeutics, Inc. reported Stockholders Equity of $53.55 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Aligos Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income Loss | -$24.2M | -$131.2M | -$87.7M | -$96.0M | -$128.3M | -$108.5M | -$52.3M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $17.0K | -$94.0K | $144.0K | -$51.0K | $640.0K | -$73.0K | -$118.0K |
| Research And Development Expense | $69.5M | $70.3M | $73.0M | $85.1M | $104.2M | $79.9M | $44.0M |
| Operating Income Loss | -$88.0M | -$89.2M | -$88.1M | -$97.6M | -$128.3M | -$97.8M | -$54.0M |
| Operating Expenses | $90.2M | $93.1M | $103.7M | $111.5M | $132.7M | $97.8M | $54.0M |
| General And Administrative Expense | $20.7M | $22.8M | $30.6M | $26.4M | $28.5M | $17.9M | $10.0M |
| Comprehensive Income Net Of Tax | -$24.2M | -$131.3M | -$87.5M | -$96.1M | -$127.7M | -$108.6M | -$52.4M |
| Income Tax Expense Benefit | $314.0K | $331.0K | $795.0K | $106.0K | $143.0K | $161.0K | $85.0K |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $22.0K | $9.0K | $96.0K | -$57.0K | |||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$23.9M | -$130.9M | -$86.9M | -$95.9M | -$128.2M | -$108.4M | |
| Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer | $0.00 | $334.0K | $9.3M | $13.9M | $4.4M | ||
| Revenue From Contract With Customer Excluding Assessed Tax | $2.2M | $3.6M | $6.2M | ||||
| Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent | $5.0K | $103.0K | -$48.0K | -$6.0K | -$749.0K | -$141.0K | $118.0K |
| Long Term Liabilities Excluding Deferred Revenue | $47.0K | $46.0K | $46.0K | $133.0K | $379.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$31.5M | -$15.9M | $43.1M | -$19.3M | $5.1M | -$34.9M | -$18.0M | -$18.8M | -$23.0M | -$18.6M | -$19.9M | -$35.6M | -$33.1M | -$29.8M | -$27.7M | -$33.3M | -$20.8M | -$20.0M | -$14.1M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $35.0K | -$27.0K | -$4.0K | $83.0K | $18.0K | -$69.0K | $0.00 | -$2.0K | $98.0K | $109.0K | -$154.0K | -$248.0K | $1.0K | -$24.0K | -$39.0K | -$118.0K | -$302.0K | $567.0K | -$38.0K |
| Research And Development Expense | $23.9M | $14.0M | $14.5M | $16.8M | $21.1M | $16.4M | $15.9M | $16.8M | $18.1M | $17.8M | $16.5M | $31.7M | $28.1M | $24.6M | $22.9M | $17.3M | $17.2M | $17.3M | $11.7M |
| Operating Income Loss | -$28.4M | -$18.6M | -$19.2M | -$20.1M | -$26.4M | -$22.0M | -$19.1M | -$19.1M | -$23.9M | -$18.9M | -$20.4M | -$35.6M | -$33.1M | -$29.6M | -$27.7M | -$21.6M | -$21.3M | -$20.7M | -$14.5M |
| Operating Expenses | $29.1M | $19.5M | $19.6M | $21.4M | $27.5M | $23.0M | $22.3M | $26.0M | $26.6M | $23.1M | $24.1M | $38.1M | $34.6M | $31.1M | $28.7M | $21.6M | $21.3M | $20.7M | $14.5M |
| General And Administrative Expense | $5.2M | $5.6M | $5.1M | $4.6M | $6.4M | $6.7M | $6.4M | $9.2M | $8.5M | $5.3M | $7.6M | $6.5M | $6.5M | $6.6M | $5.8M | $4.2M | $4.1M | $3.4M | $2.8M |
| Comprehensive Income Net Of Tax | -$31.5M | -$15.9M | $43.1M | -$19.2M | $5.1M | -$34.9M | -$18.0M | -$18.8M | -$22.9M | -$18.5M | -$20.1M | -$35.9M | -$33.1M | -$29.8M | -$27.7M | -$33.4M | -$21.1M | -$19.5M | -$14.1M |
| Income Tax Expense Benefit | $56.0K | $185.0K | $43.0K | $91.0K | $189.0K | $24.0K | $29.0K | $757.0K | $39.0K | -$43.0K | $47.0K | $53.0K | $126.0K | $28.0K | $45.0K | $0.00 | -$59.0K | ||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $35.0K | -$27.0K | -$4.0K | $83.0K | $18.0K | -$69.0K | $0.00 | -$2.0K | $98.0K | $109.0K | -$154.0K | -$248.0K | -$1.0K | -$26.0K | -$41.0K | -$105.0K | -$164.0K | $401.0K | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$31.5M | -$15.7M | $43.1M | -$19.2M | $5.3M | -$34.8M | -$18.0M | -$18.0M | -$22.9M | -$18.7M | -$19.9M | -$35.6M | -$33.0M | -$29.8M | -$27.6M | ||||
| Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer | $0.00 | $19.0K | $292.0K | $2.2M | $2.6M | $2.6M | $4.1M | $3.7M | $2.6M | $1.5M | $1.5M | $910.0K | |||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $741.0K | $965.0K | $311.0K | $1.3M | $1.1M | $694.0K | $1.1M | $4.3M | $140.0K | $0.00 | $0.00 | ||||||||
| Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent | -$2.0K | $2.0K | $2.0K | $13.0K | $138.0K | -$166.0K | $38.0K | ||||||||||||
| Long Term Liabilities Excluding Deferred Revenue | $46.0K | $46.0K | $46.0K | $46.0K | $46.0K | $46.0K | $46.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $53.5M | -$29.0M | $92.1M | $103.9M | $184.7M | $220.0M | -$64.9M | -$13.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $18.4M | $37.1M | $135.8M | $81.5M | $187.0M | $220.9M | $70.1M | $24.5M |
| Cash And Cash Equivalents At Carrying Value | $18.3M | $37.0M | $135.7M | $81.3M | $186.8M | $220.4M | $69.6M | |
| Vesting Of Early Excercised Common Stock Options Value | $66.0K | $209.0K | $292.0K | $363.0K | $26.0K | |||
| Retained Earnings Accumulated Deficit | -$642.2M | -$618.0M | -$486.8M | -$399.1M | -$303.1M | -$174.7M | -$66.2M | |
| Restricted Cash Current | $110.0K | $110.0K | $70.0K | $115.0K | $164.0K | $560.0K | $538.0K | |
| Property Plant And Equipment Net | $1.9M | $2.4M | $3.3M | $4.8M | $6.2M | $8.0M | $8.5M | |
| Other Assets Noncurrent | $715.0K | $627.0K | $625.0K | $634.0K | $866.0K | $377.0K | $188.0K | |
| Other Assets Current | $4.9M | $5.1M | $5.3M | $7.6M | $13.5M | $5.9M | $2.0M | |
| Operating Lease Right Of Use Asset Amortization Expense | $1.9M | $1.6M | $1.5M | $1.4M | $759.0K | $590.0K | $903.0K | |
| Operating Lease Right Of Use Asset | $3.1M | $5.0M | $6.6M | $7.7M | $8.8M | $6.9M | $7.6M | |
| Operating Lease Liability Noncurrent | $1.5M | $4.8M | $7.7M | $9.2M | $11.3M | $10.4M | $11.7M | |
| Operating Lease Liability Current | $3.6M | $3.4M | $3.2M | $3.0M | $2.8M | $2.4M | $2.4M | |
| Liabilities Current | $21.2M | $21.7M | $23.9M | $33.1M | $39.0M | $30.3M | $13.8M | |
| Liabilities And Stockholders Equity | $88.5M | $70.1M | $151.5M | $146.7M | $235.4M | $265.3M | $146.5M | |
| Liabilities | $35.0M | $99.1M | $59.4M | $42.8M | $50.6M | $45.3M | $29.3M | |
| Finance Lease Liability Noncurrent | $0.00 | $122.0K | $231.0K | $230.0K | $261.0K | $130.0K | $178.0K | |
| Finance Lease Liability Current | $145.0K | $36.0K | $10.0K | $108.0K | $138.0K | $64.0K | $74.0K | |
| Common Stock Value | $9.0K | $8.0K | $7.0K | $4.0K | $4.0K | $4.0K | $0.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$18.7M | -$98.7M | $54.3M | -$105.5M | -$34.0M | $150.8M | $45.6M | |
| Assets Current | $82.9M | $62.1M | $141.1M | $133.5M | $204.4M | $250.0M | $120.2M | |
| Assets | $88.5M | $70.1M | $151.5M | $146.7M | $235.4M | $265.3M | $146.5M | |
| Additional Paid In Capital Common Stock | $695.3M | $588.6M | $578.3M | $502.6M | $487.3M | $395.0M | $1.4M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $468.0K | $451.0K | $545.0K | $401.0K | $452.0K | -$188.0K | -$115.0K | |
| Accrued Liabilities Current | $13.5M | $15.6M | $16.8M | $16.0M | $25.4M | $16.6M | $7.6M | |
| Accretion Amortization Of Discounts And Premiums Investments | $2.2M | $1.8M | $424.0K | $159.0K | -$86.0K | -$234.0K | $877.0K | |
| Accounts Payable Current | $4.0M | $2.6M | $2.5M | $4.7M | $3.0M | $3.3M | $3.8M | |
| Finance Lease Principal Payments | $14.0K | $83.0K | $96.0K | $61.0K | $79.0K | $58.0K | $43.0K | |
| Short Term Investments | $59.5M | $19.9M | $44.5M | $3.9M | $23.1M | $48.1M | ||
| Restricted Cash | $110.0K | $70.0K | $115.0K | $164.0K | $560.0K | $538.0K | ||
| Market To Market Adjustments For Available For Sale Investments | $9.0K | $96.0K | -$57.0K | -$109.0K | $68.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $71.8M | $101.9M | $116.4M | $50.1M | $67.2M | $59.8M | $54.8M | $69.6M | $84.8M | $122.0M | $137.0M | $152.9M | $217.0M | $168.9M | $195.2M | -$136.7M | -$104.6M | -$83.9M | -$47.0M | -$33.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $42.1M | $18.8M | $73.9M | $35.4M | $45.1M | $24.4M | $70.5M | $90.9M | $79.1M | $86.5M | $71.2M | $106.1M | $240.4M | $187.8M | $200.9M | $32.4M | $23.2M | $26.0M | $21.7M | |
| Cash And Cash Equivalents At Carrying Value | $41.9M | $18.7M | $73.8M | $35.3M | $45.1M | $24.2M | $70.4M | $90.8M | $78.7M | $86.4M | $71.2M | $104.6M | $239.7M | $187.7M | $200.4M | $31.8M | $22.7M | $25.4M | $21.1M | |
| Vesting Of Early Excercised Common Stock Options Value | $18.0K | $20.0K | $20.0K | $44.0K | $60.0K | $84.0K | $82.0K | $84.0K | $42.0K | $156.0K | $64.0K | $224.0K | ||||||||
| Retained Earnings Accumulated Deficit | -$622.3M | -$590.8M | -$574.9M | -$535.9M | -$516.6M | -$521.7M | -$458.9M | -$440.9M | -$422.1M | -$377.2M | -$358.6M | -$338.7M | -$265.4M | -$232.2M | -$202.4M | -$140.3M | ||||
| Restricted Cash Current | $110.0K | $110.0K | $110.0K | $110.0K | $70.0K | $216.0K | $74.0K | $42.0K | $397.0K | $80.0K | $21.0K | $1.6M | $653.0K | $193.0K | $556.0K | $556.0K | ||||
| Property Plant And Equipment Net | $2.0M | $2.1M | $2.2M | $2.6M | $2.8M | $3.0M | $3.6M | $4.0M | $4.4M | $5.3M | $5.8M | $6.0M | $6.3M | $7.0M | $7.6M | $8.6M | ||||
| Other Assets Noncurrent | $713.0K | $640.0K | $632.0K | $635.0K | $631.0K | $625.0K | $623.0K | $624.0K | $632.0K | $653.0K | $616.0K | $616.0K | $748.0K | $1.5M | $188.0K | $2.8M | ||||
| Other Assets Current | $4.2M | $4.9M | $5.2M | $4.8M | $5.0M | $5.1M | $4.1M | $3.4M | $5.5M | $7.7M | $8.3M | $10.3M | $5.8M | $5.8M | $5.9M | $3.1M | ||||
| Operating Lease Right Of Use Asset Amortization Expense | $316.0K | $392.0K | $390.0K | $307.0K | $132.0K | $129.0K | ||||||||||||||
| Operating Lease Right Of Use Asset | $3.6M | $4.1M | $4.6M | $5.4M | $5.8M | $6.2M | $6.9M | $7.3M | $7.3M | $8.1M | $8.4M | $8.8M | $6.9M | $6.8M | $7.0M | $7.1M | ||||
| Operating Lease Liability Noncurrent | $2.4M | $3.2M | $4.3M | $5.5M | $6.3M | $7.0M | $8.3M | $9.0M | $8.6M | $9.7M | $10.3M | $10.9M | $9.6M | $9.8M | $10.2M | $10.7M | ||||
| Operating Lease Liability Current | $3.5M | $3.5M | $3.5M | $3.4M | $3.4M | $3.3M | $3.2M | $3.2M | $3.0M | $3.1M | $2.8M | $3.2M | $2.7M | $2.6M | $2.5M | $2.4M | ||||
| Liabilities Current | $22.0M | $20.3M | $18.9M | $21.0M | $23.6M | $18.9M | $22.5M | $27.2M | $28.1M | $30.5M | $31.7M | $41.4M | $34.8M | $30.1M | $25.2M | $20.0M | ||||
| Liabilities And Stockholders Equity | $109.8M | $134.7M | $150.7M | $88.4M | $108.8M | $127.9M | $85.9M | $106.1M | $121.7M | $164.1M | $182.5M | $210.5M | $263.1M | $211.9M | $234.5M | $92.2M | ||||
| Liabilities | $37.9M | $32.8M | $34.3M | $38.3M | $41.6M | $68.1M | $31.0M | $36.5M | $37.0M | $42.1M | $45.5M | $57.6M | $46.1M | $43.0M | $39.3M | $46.3M | ||||
| Finance Lease Liability Noncurrent | $122.0K | $122.0K | $122.0K | $188.0K | $203.0K | $217.0K | $188.0K | $203.0K | $205.0K | $174.0K | $201.0K | $231.0K | $53.0K | $130.0K | $130.0K | $130.0K | ||||
| Finance Lease Liability Current | $21.0K | $38.0K | $37.0K | $13.0K | $4.0K | $5.0K | $58.0K | $64.0K | $108.0K | $138.0K | $138.0K | $138.0K | $81.0K | $26.0K | $45.0K | $76.0K | ||||
| Common Stock Value | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | $7.0K | $4.0K | $0.00 | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $0.00 | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $36.8M | -$111.4M | -$2.4M | -$80.9M | -$20.0M | -$44.1M | ||||||||||||||
| Assets Current | $103.4M | $127.9M | $143.2M | $79.8M | $99.6M | $118.1M | $74.6M | $94.2M | $109.4M | $150.1M | $167.7M | $195.1M | $248.7M | $196.6M | $219.8M | $73.7M | ||||
| Assets | $109.8M | $134.7M | $150.7M | $88.4M | $108.8M | $127.9M | $85.9M | $106.1M | $121.7M | $164.1M | $182.5M | $210.5M | $263.1M | $211.9M | $234.5M | $92.2M | ||||
| Additional Paid In Capital Common Stock | $693.7M | $692.2M | $690.9M | $585.4M | $583.3M | $581.0M | $513.2M | $510.0M | $506.3M | $499.1M | $495.5M | $491.4M | $482.6M | $401.4M | $397.9M | $3.6M | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $455.0K | $420.0K | $447.0K | $577.0K | $494.0K | $476.0K | $497.0K | $497.0K | $499.0K | $159.0K | $50.0K | $204.0K | -$250.0K | -$251.0K | -$227.0K | $32.0K | ||||
| Accrued Liabilities Current | $13.6M | $12.2M | $11.0M | $14.2M | $12.1M | $12.0M | $12.3M | $13.8M | $15.1M | $13.7M | $12.8M | $19.2M | $22.8M | $19.1M | $12.3M | $9.8M | ||||
| Accretion Amortization Of Discounts And Premiums Investments | $137.0K | $84.0K | $267.0K | -$9.0K | -$37.0K | -$5.0K | ||||||||||||||
| Accounts Payable Current | $4.7M | $3.9M | $4.5M | $2.7M | $6.8M | $2.8M | $2.9M | $3.2M | $2.8M | $2.9M | $2.8M | $3.8M | $2.6M | $1.6M | $2.8M | $7.7M | ||||
| Finance Lease Principal Payments | $19.0K | $24.0K | $31.0K | $18.0K | $11.0K | |||||||||||||||
| Short Term Investments | $57.2M | $104.3M | $64.1M | $39.6M | $49.5M | $88.6M | $10.0K | $24.8M | $55.9M | $88.2M | $78.7M | $2.5M | $3.0M | $13.1M | ||||||
| Restricted Cash | $110.0K | $70.0K | $216.0K | $74.0K | $42.0K | $397.0K | $80.0K | $21.0K | $1.6M | $653.0K | $193.0K | $556.0K | $556.0K | $553.0K | $552.0K | $537.0K | ||||
| Market To Market Adjustments For Available For Sale Investments | -$69.0K | $98.0K | -$248.0K | -$41.0K | $401.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition | $503.0K | $504.0K | $853.0K | $1.3M | $795.0K | ||
| Share Based Compensation | $5.0M | $8.5M | $12.7M | $14.7M | $13.5M | $3.0M | $752.0K |
| Net Cash Provided By Used In Operating Activities | -$82.5M | -$80.7M | -$79.0M | -$79.4M | -$115.7M | -$74.3M | -$46.8M |
| Net Cash Provided By Used In Investing Activities | -$37.8M | -$18.3M | $45.0M | -$26.3M | $3.0M | $32.8M | $6.8M |
| Net Cash Provided By Used In Financing Activities | $101.6M | $355.0K | $88.3M | $164.0K | $78.7M | $192.3M | $85.5M |
| Increase Decrease In Other Current Assets | -$96.0K | -$216.0K | -$2.3M | -$5.6M | $8.1M | $4.1M | $1.0M |
| Increase Decrease In Operating Lease Liabilities | -$3.1M | -$2.7M | -$2.4M | -$1.8M | -$1.4M | -$1.3M | -$1.0K |
| Increase Decrease In Accrued Liabilities | -$2.0M | -$1.4M | $918.0K | -$9.1M | $9.7M | $9.6M | $4.2M |
| Increase Decrease In Accounts Payable | $1.4M | $54.0K | -$2.2M | $1.7M | -$313.0K | -$130.0K | $385.0K |
| Payments To Acquire Short Term Investments | $164.9M | $108.1M | $11.0K | $104.3M | $2.7M | $32.1M | $60.4M |
| Increase Decrease In Deferred Revenue | -$151.0K | -$1.2M | -$8.1M | $2.5M | -$4.4M | ||
| Payments To Acquire Property Plant And Equipment | $130.0K | $19.0K | $943.0K | $892.0K | $2.1M | $2.8M | |
| Proceeds From Stock Options Exercised | $260.0K | $487.0K | |||||
| Proceeds From Sale Maturity And Collection Of Shortterm Investments | $127.5M | $90.0M | $45.0M | $78.9M | $23.0M | $80.1M | $80.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition | $199.0K | $110.0K | $50.0K | $139.0K | $138.0K | $148.0K | $326.0K | $222.0K | $161.0K | $219.0K | $447.0K | $444.0K | ||
| Share Based Compensation | $959.0K | $2.6M | $3.7M | $3.8M | $2.8M | $606.0K | ||||||||
| Net Cash Provided By Used In Operating Activities | -$20.9M | -$22.7M | -$22.4M | -$20.4M | -$29.8M | -$20.3M | ||||||||
| Net Cash Provided By Used In Investing Activities | -$44.1M | -$88.6M | $20.0M | -$60.4M | $9.7M | -$23.8M | ||||||||
| Net Cash Provided By Used In Financing Activities | $101.7M | -$19.0K | -$1.0K | -$21.0K | $78.0K | -$48.0K | ||||||||
| Increase Decrease In Other Current Assets | $147.0K | -$204.0K | -$2.1M | -$3.6M | -$277.0K | $528.0K | ||||||||
| Increase Decrease In Operating Lease Liabilities | -$502.0K | -$636.0K | -$584.0K | -$47.0K | -$303.0K | -$277.0K | ||||||||
| Increase Decrease In Accrued Liabilities | -$4.8M | -$4.8M | -$937.0K | -$6.1M | -$4.2M | $183.0K | ||||||||
| Increase Decrease In Accounts Payable | $1.7M | $325.0K | -$1.9M | $740.0K | -$502.0K | -$304.0K | ||||||||
| Payments To Acquire Short Term Investments | $64.0M | $88.6M | $0.00 | $59.9M | $32.1M | |||||||||
| Increase Decrease In Deferred Revenue | -$151.0K | -$587.0K | -$2.3M | $12.4M | -$910.0K | |||||||||
| Payments To Acquire Property Plant And Equipment | $7.0K | $515.0K | $307.0K | $1.1M | ||||||||||
| Proceeds From Stock Options Exercised | $23.0K | $10.0K | $96.0K | $18.0K | ||||||||||
| Proceeds From Sale Maturity And Collection Of Shortterm Investments | $20.0M | $20.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$2.45 | -$20.94 | -$34.20 | -$2.25 | -$3.22 | -$10.87 | -$26.04 | |
| Common Stock Shares Authorized | 115.8M | 20.8M | 12.8M | 320.0M | 320.0M | 320.0M | 278.0M | 25.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Issued | 6.2M | 3.9M | 3.0M | 42.9M | 42.7M | 38.1M | 3.9M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Common Stock Shares Outstanding | 6.2M | 3.9M | 3.0M | 42.9M | 42.7M | 38.1M | 3.9M | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||
| Weighted Average Number Of Shares Outstanding Basic | 9.9M | 6.3M | 2.6M | 42.7M | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 9.9M | 6.3M | 2.6M | 42.7M | ||||
| Earnings Per Share Basic | $-2.45 | $-20.94 | $-34.20 | $-2.25 | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 42.7M | 39.9M | 10.0M | 2.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$3.04 | -$1.53 | -$2.11 | -$3.07 | $0.81 | -$5.58 | -$10.37 | -$0.43 | -$0.53 | -$0.44 | -$0.47 | -$0.84 | -$0.78 | -$0.79 | -$0.74 | -$11.00 | -$7.40 | -$7.56 | -$6.74 |
| Common Stock Shares Authorized | 115.8M | 115.8M | 20.8M | 20.8M | 520.0M | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | 278.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Issued | 6.2M | 6.2M | 6.1M | 3.3M | 79.8M | 75.7M | 43.5M | 43.5M | 42.9M | 42.8M | 42.8M | 42.7M | 42.6M | 38.2M | 38.1M | 4.1M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Common Stock Shares Outstanding | 6.2M | 6.2M | 6.1M | 3.3M | 79.8M | 75.7M | 43.5M | 43.5M | 42.9M | 42.8M | 42.8M | 42.7M | 42.6M | 38.2M | 38.1M | 4.1M | |||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||
| Weighted Average Number Of Shares Outstanding Basic | 10.4M | 10.4M | 8.4M | 6.3M | 6.3M | 6.2M | 1.7M | 43.2M | 42.9M | 42.8M | 42.7M | 42.5M | 42.4M | ||||||
| Weighted Average Number Of Diluted Shares Outstanding | 10.4M | 10.4M | 8.7M | 6.3M | 6.3M | 6.2M | 1.7M | 43.2M | 42.9M | 42.8M | 42.7M | 42.5M | 42.4M | ||||||
| Earnings Per Share Basic | $-3.04 | $-1.53 | $5.12 | $-3.07 | $0.81 | $-5.58 | $-10.37 | $-0.43 | $-0.53 | $-0.44 | $-0.47 | $-0.84 | $-0.78 | ||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 42.7M | 42.5M | 42.4M | 37.6M | 37.4M | 3.0M | 2.8M | 2.6M | 2.1M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Other Operating Income Expense Net | $3.9M | $4.4M | $3.4M | $1.6M | $132.0K | -$10.5M | $1.9M |
| Depreciation | $930.0K | $1.0M | $1.6M | $2.3M | $3.0M | $2.7M | $1.4M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition | $4.5M | $7.9M | $11.8M | $13.5M | $12.5M | ||
| Stock Issued During Period Value Stock Options Exercised | $23.0K | $20.0K | $394.0K | $261.0K | $461.0K | ||
| Vesting Of Early Exercised Options Value | $66.0K | $209.0K | $292.0K | $363.0K | |||
| Stock Issued During Period Value Employee Stock Purchase Plan | $304.0K | $436.0K | $551.0K | $205.0K | $653.0K | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $3.0M | $752.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Operating Income Expense Net | $1.1M | $1.2M | $880.0K | $1.1M | $1.2M | $1.6M | $1.1M | $1.1M | $1.0M | $284.0K | $516.0K | -$5.0K | $70.0K | -$225.0K | $111.0K | -$11.7M | $415.0K | $692.0K | $453.0K |
| Depreciation | $200.0K | $300.0K | $194.0K | $300.0K | $300.0K | $282.0K | $300.0K | $400.0K | $454.0K | $500.0K | $600.0K | $676.0K | $800.0K | $800.0K | $741.0K | $708.0K | $680.0K | $331.0K | $387.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition | $1.3M | $1.1M | $909.0K | $1.9M | $1.9M | $2.5M | $2.9M | $3.0M | $3.5M | $3.3M | $3.6M | $3.5M | |||||||
| Stock Issued During Period Value Stock Options Exercised | $23.0K | $9.0K | $1.0K | $10.0K | $18.0K | $213.0K | $96.0K | $148.0K | $76.0K | $18.0K | $70.0K | ||||||||
| Vesting Of Early Exercised Options Value | $20.0K | $84.0K | $42.0K | $63.0K | |||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $180.0K | $297.0K | $461.0K | $111.0K | |||||||||||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $3.3M | $3.2M | $2.8M | $1.0M | $327.0K | $331.0K | $151.0K |
Most recent annual filing with the SEC: March 5, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.